Home/Filings/4/0001209191-21-066283
4//SEC Filing

Stewart Christopher P. 4

Accession 0001209191-21-066283

CIK 0001411690other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 6:00 AM ET

Size

7.4 KB

Accession

0001209191-21-066283

Insider Transaction Report

Form 4
Period: 2021-11-19
Stewart Christopher P.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-19$0.56/sh+22,500$12,60055,500 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-11-1922,500177,500 total
    Exercise: $0.56Exp: 2030-09-01Common Stock (22,500 underlying)
Footnotes (1)
  • [F1]The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.

Issuer

Bionano Genomics, Inc.

CIK 0001411690

Entity typeother

Related Parties

1
  • filerCIK 0001822991

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:00 AM ET
Size
7.4 KB